Holmes’ Partner Launches New Blood-Testing Startup Amidst Legal Turmoil

The Bay Area is once again in the spotlight of a potential medical scandal. Billy Evans, the former partner of Elizabeth Holmes, the convicted founder of the failed blood-testing company Theranos, is launching his own blood-testing startup. According to a New York Times report, Evans is seeking to raise nearly \$50 million from investors. This news comes just days after a court denied Holmes a new trial. Tech experts are expressing concerns, noting the eerie similarities between Evans’ new venture and Theranos’ failed model. Tim Bajarin, from Creative Strategies, Inc., commented, "I can't say that they're not going to get funding, but it's going to be highly scrutinized because of the link to Theranos." Kym Mcnicholas, CEO & Co-founder of Global PAD Association, added, "There are millions of lives at stake with every one of these medical companies, and you can't just show any sort of leniency when it comes to someone's life or limb." Evans' attempt to secure funding and the ongoing legal battles surrounding Holmes highlight the complexities and risks within the medical technology industry. The situation serves as a reminder of the importance of thorough due diligence and ethical considerations in the pursuit of medical innovation.